F D C Ltd
NSE:FDC

Watchlist Manager
F D C Ltd Logo
F D C Ltd
NSE:FDC
Watchlist
Price: 419.55 INR 0.17% Market Closed
Market Cap: 68.3B INR

Relative Value

The Relative Value of one FDC stock under the Base Case scenario is hidden INR. Compared to the current market price of 419.55 INR, F D C Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FDC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
60
vs Industry
35
Median 3Y
3.5
Median 5Y
3.5
Industry
2.6
vs History
7
vs Industry
19
Median 3Y
25.7
Median 5Y
24.4
Industry
21.4
vs History
6
vs Industry
20
Median 3Y
31.7
Median 5Y
28.1
Industry
16.4
vs History
vs Industry
17
Median 3Y
37.1
Median 5Y
37
Industry
22.8
vs History
61
vs Industry
25
Median 3Y
3.2
Median 5Y
3
Industry
2.2
vs History
57
vs Industry
38
Median 3Y
3.2
Median 5Y
3.2
Industry
2.9
vs History
61
vs Industry
43
Median 3Y
5
Median 5Y
4.9
Industry
5.5
vs History
14
vs Industry
19
Median 3Y
20.1
Median 5Y
18.4
Industry
13
vs History
4
vs Industry
20
Median 3Y
23.2
Median 5Y
22
Industry
16.5
vs History
6
vs Industry
23
Median 3Y
29.6
Median 5Y
25.5
Industry
15.6
vs History
vs Industry
19
Median 3Y
33.2
Median 5Y
32.3
Industry
18.7
vs History
68
vs Industry
23
Median 3Y
3.4
Median 5Y
3.3
Industry
1.9

Multiples Across Competitors

FDC Competitors Multiples
F D C Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
F D C Ltd
NSE:FDC
68.3B INR 3.3 30.3 23.1 29.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
IN
F D C Ltd
NSE:FDC
Average P/E: 25
30.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
F D C Ltd
NSE:FDC
Average EV/EBITDA: 401.9
23.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
F D C Ltd
NSE:FDC
Average EV/EBIT: 1 714.8
29.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5